Breast cancer and endometriosis drug Zoladex is being pulled from Australia. How will women be affected?

Manufactured by AstraZeneca, Zoladex provides pain relief for women with endometriosis and is a treatment for breast cancer. Photograph: Olena Malik/Getty Images

Thousands of women could be left without vital breast cancer and endometriosis medicine when AstraZeneca removes its treatment from the Pharmaceutical Benefits Scheme (PBS) and the private market, experts warn.

Zoladex will no longer be available in Australia from November, as the ABC first reported, but some existing patients will still be able to access it for an additional six months.